Shares of Target fell Tuesday morning after the company said higher wages put pressure on profits during the holiday quarter. And Amazon shares are at a new record high, thanks to a new $2,000 price target from Monness Crespi. Plus we speak with the SVP of global brands at Wyndham about the company's plans to spin off its vacation ownership business into a separate public company, as well as a new feature that gets you to unplug. And Spotify and Dropbox have both filed to go public in recent weeks. We take a look at how the offerings may fare and what precedent they set for the IPO market this year. Analysts at Baird reiterated their "outperform" rating on Apple stock, with a price target of $200. Kristen Scholer and Tim Stenovec walk you through setting a limit sell order on the TradeStation platform if you want to lock in gains if and when the stock hits that level.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More